AKOSUA NTI, MD
Ophthalmology Physician · BALTIMORE, MD
Individual Active NPI 1437569936
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 789 | 16,647 | $9,113,028 | $2,881,402 | $2,271,509 |
| 2023 | 772 | 11,795 | $7,538,232 | $2,094,532 | $1,644,160 |
| 2022 | 682 | 6,507 | $4,326,613 | $1,245,196 | $986,100 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,660 | $35 | $28 |
| J0177 | Injection, aflibercept hd, 1 mg | 3,096 | $332 | $264 |
| 92014 | Established patient complete exam of visual system | 1,769 | $143 | $106 |
| 92134 | Imaging of retina | 1,694 | $46 | $36 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,390 | $229 | $183 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 1,381 | $17 | $13 |
| 67028 | Injection of drug into eye | 1,123 | $133 | $103 |
| J0178 | Injection, aflibercept, 1 mg | 480 | $826 | $658 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 256 | $28 | $20 |
| 92250 | Photography of the retina | 161 | $40 | $32 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 146 | $188 | $136 |
| 92012 | Established patient problem focused exam of visual system | 114 | $102 | $81 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | D85472 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Maryland
- NPI 1770182560
- NPI 1174537534
- NPI 1396494118
- NPI 1578609962
- NPI 1427010107
- NPI 1437277209
- NPI 1396887014
- NPI 1497371892
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.